Misdiagnosed Malaria? Dengue & Malaria Confusion
- A recent study in Kenya highlights the challenge of distinguishing between malaria and dengue fever, two mosquito-borne illnesses with similar symptoms such as fever and headache.The research suggests...
- The study, which examined over 1,000 children with fevers visiting outpatient clinics in western and coastal Kenya between 2014 and 2017, found that 40% had evidence of the...
- Researchers were surprised by the high number of concurrent serotype infections, including DENV-4, which is typically underreported in Africa. The study also found that half of the children...
Uncover teh realities of misdiagnosed dengue fever in Africa. A critical Kenyan study reveals that dengue is often overlooked in children presenting with fever, leading to unneeded treatments and possibly masking the true scale of the illness. Researchers found a important percentage of children tested positive for the dengue virus,raising concerns about the over-prescription of anti-malarial and antimicrobial drugs,which could lead to drug resistance. This impacts thousands across the continent, potentially increasing the cases far beyond official counts. The research underscores the need for improved diagnostics to differentiate between dengue and malaria. News Directory 3 is closely following this story. discover what’s next for patient care and public health initiatives in the face of this growing challenge.
Kenya Study: Dengue Misdiagnosis May Mask True Burden in Africa
Updated May 28, 2025
A recent study in Kenya highlights the challenge of distinguishing between malaria and dengue fever, two mosquito-borne illnesses with similar symptoms such as fever and headache.The research suggests that dengue is frequently undiagnosed in Kenyan children,leading to inappropriate treatment with anti-malarial and anti-microbial drugs. This raises concerns that the actual burden of dengue in Africa is substantially higher than current estimates.
The study, which examined over 1,000 children with fevers visiting outpatient clinics in western and coastal Kenya between 2014 and 2017, found that 40% had evidence of the dengue virus in their bloodstreams. These high levels of dengue in Kenya were often missed due to overlapping symptoms with other diseases.
Researchers were surprised by the high number of concurrent serotype infections, including DENV-4, which is typically underreported in Africa. The study also found that half of the children with dengue also had malaria, further complicating diagnosis and treatment.
The research indicated that children with dengue received anti-malarial and anti-microbial prescriptions at a higher rate, suggesting that doctors may have misattributed the fever to malaria or another infection. this over-prescription of medications can lead to drug resistance and unwanted side effects.
The study emphasizes the importance of accurate diagnosis,noting that asymptomatic dengue infections contribute significantly to the transmission of the virus. Of the 141 children with dengue but not malaria, a significant number received unnecessary anti-malarial or anti-microbial drugs, reinforcing concerns about over-diagnosis of malaria and the routine use of anti-microbials for fevers of unknown origin.
The study noted that “the level of dengue we detected was surprisingly high” and “the number of concomitant (concurrent) serotype infections was also high and unexpected”.
What’s next
The study concludes with a call for increased investment in reliable point-of-care diagnostics for dengue and a better understanding of the spatial-temporal dynamics of dengue circulation in Africa. This knowledge is crucial for informing a coordinated public health response in an increasingly interconnected world, helping to combat the spread of dengue and improve patient outcomes.
